Swedencare AB (publ) (STO: SECARE)

Market Cap	6.47B
Revenue (ttm)	2.47B
Net Income (ttm)	76.10M
Shares Out	158.86M
EPS (ttm)	0.48
PE Ratio	84.98
Forward PE	27.07
Dividend	0.23 (0.56%)
Ex-Dividend Date	Apr 26, 2024

Volume	120,131
Open	40.50
Previous Close	40.30
Day's Range	40.02 - 41.48
52-Week Range	32.56 - 69.12
Beta	0.98
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Swedencare AB

Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally. The company offers animal nutritional supplements, treats, and grooming products under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 559
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SECARE

Financial Performance

In 2023, Swedencare AB's revenue was 2.34 billion, an increase of 26.85% compared to the previous year's 1.84 billion. Earnings were 58.60 million, a decrease of -37.99%.